Brief: Quantum Genomics recruits first patients in NEW-HOPE hypertension study in the US

Quantum Genomics SA

15/11/2017 06:31

Nov 15 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA : 
    * QUANTUM GENOMICS ANNOUNCES RECRUITMENT OF FIRST PATIENTS 
IN 
NEW-HOPE ARTERIAL HYPERTENSION STUDY IN UNITED STATES 
    * PATIENTS IN UNITED STATES TO PARTICIPATE IN NEW-HOPE 
STUDY, 
DESIGNED TO EVALUATE EFFICACY OF DRUG CANDIDATE QGC001 IN 
TREATMENT OF HIGH BLOOD PRESSURE 
    * STUDY RESULTS ARE EXPECTED IN FIRST HALF OF 2019 
    * PRIMARY EFFICACY ENDPOINT IS A LOWER BLOOD PRESSURE 
READING 
AFTER EIGHT-WEEK PERIOD 
 
Source text for Eikon:  ID:nACT51041  
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))